Screening for prostate cancer remains controversial. BMJ (Clinical research ed.) [BMJ] Journal article

Title	Screening for prostate cancer remains controversial.
Author(s)	Stark JR, Mucci L, Rothman KJ, Adami HO
Institution	Department of Epidemiology, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA 02115, USA. stark@hsph.harvard.edu
Source	BMJ 2009.:b3601.
MeSH	Costs and Cost Analysis Early Detection of Cancer Humans Male Mass Screening Middle Aged Patient Selection Practice Guidelines as Topic Prostate-Specific Antigen Prostatic Neoplasms Quality-Adjusted Life Years Randomized Controlled Trials as Topic Risk Factors Sensitivity and Specificity Treatment Outcome
Language	eng
Pub Type(s)	Journal Article
PubMed ID	19778971

Advertise on this site.